Clinical and Microbiological Characteristics of Rhizobium radiobacter Infections
Journal
Clinical Infectious Diseases
Journal Volume
38
Journal Issue
1
Pages
149-153
Date Issued
2004
Author(s)
Abstract
Data obtained from 1996 to 2002 on 13 patients with Rhizobium radiobacter infections were analyzed. Ten patients (76%) had underlying hematological malignancy or solid-organ cancer. Six patients (46%) had febrile neutropenia during the course of R. radiobacter infection. The majority (54%) of infections were catheter-related bacteremia, and 92% of infections were hospital acquired. All the patients survived. Eighteen isolates were recovered from the 13 patients, and each isolate was susceptible to cefepime, piperacillin-tazobactam, carbapenems, and ciprofloxacin. The pulsed-field gel electrophoresis profiles differed among the isolates recovered from different patients, indicating the absence of nosocomial spread of the organism.
SDGs
Other Subjects
amikacin; amoxicillin plus clavulanic acid; aztreonam; carbapenem derivative; cefepime; cefmetazole; cefoperazone; cefotaxime; cefpirome; ceftazidime; ceftriaxone; ciprofloxacin; garenoxacin; gentamicin; imipenem; meropenem; moxifloxacin; piperacillin plus tazobactam; sultamicillin; tobramycin; trovafloxacin; adult; aged; article; bacterial infection; catheter; clinical article; controlled study; disease course; drug sensitivity; febrile neutropenia; female; hairy root disease; hematologic malignancy; hospital infection; human; male; priority journal; pulsed field gel electrophoresis; Rhizobium radiobacter; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Female; Gram-Negative Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Rhizobium radiobacter
Type
journal article